Coley Pharmaceutical Group is Pharmaceuticals in United States that focus on respiratory disorders business. Founded in 1997. They cover business area such as operator, drug candidate, cancer, infectious disease, respiratory disorder, pharmaceutical platform specialize, vaccine adjuvant technology, allergy, asthma disorder, autoimmune disease, physician, important immune system receptor, turn.
1997
( 27 years old in 2024 )
Respiratory Disorders
-
93 Worcester Street
Suite 101
Wellesley, MA 02481
United States
Private
operatordrug candidatecancerinfectious diseaserespiratory disorderpharmaceutical platform specializevaccine adjuvant technologyallergyasthma disorderautoimmune diseasephysicianimportant immune system receptorturn
* We use standard office opening hours in near Coley Pharmaceutical Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Coley Pharmaceutical Group is Pharmaceuticals business from United States that founded in 1997 (27 years old in 2024), Coley Pharmaceutical Group business is focusing on Respiratory Disorders.
Coley Pharmaceutical Group headquarter office and corporate office address is located in 93 Worcester Street Suite 101 Wellesley, MA 02481 United States.
Coley Pharmaceutical Group was founded in United States.
In 2024, Coley Pharmaceutical Group is currently focus on respiratory disorders sector.
Above is snippet of Google Trends for "respiratory disorders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Coley Pharmaceutical Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
